Literature DB >> 7036741

Disorders of body fluids, sodium and potassium in chronic renal failure.

W E Mitch, C S Wilcox.   

Abstract

A stable volume and composition of extracellular fluid are essential for normal functioning of the body. Since the kidney is primarily responsible for regulating extracellular fluid, loss of kidney function should have catastrophic consequences. Fortunately, even with loss of more than 90 percent of renal function, a remarkable capacity to regulate body fluid volumes and sodium and potassium persists. Nevertheless, this capacity is limited to chronic renal disease and this has important consequences for clinical management of these patients. How can sodium and potassium homeostasis be assessed? Methods for evaluating the steady-state regulation of sodium include measurement of body fluids and their distribution in different compartments and measurement of exchangeable and intracellular sodium. Short-term regulation of body sodium can be assessed from measurement of sodium balance during changes in dietary salt. Potassium is predominantly contained within cells and thus the assessment of its regulation requires special emphasis on measurement of steady-state body stores and potassium distribution across cell membranes. However, the methods used to make all of these measurements require assumptions that may not hold in the altered state of uremia. This raises problems in interpretation requiring critical analysis before conclusions can be made regarding sodium and potassium homeostasis in patients with chronic renal failure. This review focuses on abnormalities of body fluids, sodium and potassium in patients with creatinine clearances of less than 20 ml/min due to chronic renal failure and the impact of conservative therapy, dialysis and renal transplantation on these patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7036741     DOI: 10.1016/0002-9343(82)90523-x

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  17 in total

1.  Renal dysfunction in children.

Authors:  V G Nieto; M L Erice
Journal:  Pediatr Nephrol       Date:  1990-03       Impact factor: 3.714

2.  Hyperkalaemic cardiac arrest successfully treated with peritoneal dialysis.

Authors:  M A Jackson; R Lodwick; S G Hutchinson
Journal:  BMJ       Date:  1996-05-18

Review 3.  Clinical Pharmacology Studies in Critically Ill Children.

Authors:  Nilay Thakkar; Sara Salerno; Christoph P Hornik; Daniel Gonzalez
Journal:  Pharm Res       Date:  2016-09-01       Impact factor: 4.200

Review 4.  Effects of aging and comorbidities on nutritional status and muscle dysfunction in patients with COPD.

Authors:  Bruno-Pierre Dubé; Pierantonio Laveneziana
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

Review 5.  Mineralocorticoid receptor blockade in chronic kidney disease.

Authors:  Matthew J Volk; Andrew S Bomback; Philip J Klemmer
Journal:  Curr Hypertens Rep       Date:  2011-08       Impact factor: 5.369

6.  Myogenic responses of mouse isolated perfused renal afferent arterioles: effects of salt intake and reduced renal mass.

Authors:  En Yin Lai; Maristela L Onozato; Glenn Solis; Shakil Aslam; William J Welch; Christopher S Wilcox
Journal:  Hypertension       Date:  2010-03-01       Impact factor: 10.190

Review 7.  Hyperkalemia in patients undergoing hemodialysis: Its pathophysiology and management.

Authors:  Shigeru Shibata; Shunya Uchida
Journal:  Ther Apher Dial       Date:  2021-08-31       Impact factor: 2.195

Review 8.  Potassium and anaesthesia.

Authors:  J E Tetzlaff; J F O'Hara; M T Walsh
Journal:  Can J Anaesth       Date:  1993-03       Impact factor: 5.063

Review 9.  Urea and Ammonia Metabolism and the Control of Renal Nitrogen Excretion.

Authors:  I David Weiner; William E Mitch; Jeff M Sands
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-30       Impact factor: 8.237

10.  Cardiovascular-renal axis disorders in the domestic dog and cat: a veterinary consensus statement.

Authors:  J L Pouchelon; C E Atkins; C Bussadori; M A Oyama; S L Vaden; J D Bonagura; V Chetboul; L D Cowgill; J Elliot; T Francey; G F Grauer; V Luis Fuentes; N Sydney Moise; D J Polzin; A M Van Dongen; N Van Israël
Journal:  J Small Anim Pract       Date:  2015-09       Impact factor: 1.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.